Congress | Page 24 of 26 | SpiritIndia.com

Smoking :: New Study Critical of Tobacco Industry’s Youth Prevention Campaigns

An important new study released finds that the tobacco companies’ youth prevention campaigns do nothing to reduce youth smoking rates and the industry?s parent-focused ads may actually increase intention to smoke among older teens. The findings, published in the latest edition of the American Journal of Public Health, are further evidence that Big Tobacco cannot be the source for kids when it comes to learning about the dangers associated with tobacco use.

Restless Legs Syndrome :: Boehringer Ingelheim’s pramipexole effective in RLS patients

New data presented today show patients taking pramipexole (Mirapexin?/ Sifrol?) can experience significant improvements in a broad range of symptoms associated with Restless Legs Syndrome (RLS).1 In an additional study presented today, pramipexole was also shown to be well tolerated in RLS patients affected by concomitant diseases, which are commonly experienced in this patient group.2 The results of the studies were presented at the 10th International Congress of Parkinson?s Disease and Movement Disorders (MDS) in Kyoto, Japan.

Parkinson’s Disease :: Boehringer Ingelheim’s pramipexole, mirapexin/sifrol to improve depressive and motivational symptoms

New data presented today from a meta-analysis* of nearly 1,300 Parkinson?s disease (PD) patients, indicate that pramipexole (Mirapexin?/Sifrol?) has a beneficial effect on depressive and motivational symptoms in PD.1 This confirms findings from previously published clinical trials,2,3,4 and is in addition to its established efficacy in controlling motor symptoms. These findings are of particular interest as mood symptoms in PD can affect up to 50 percent of the patient population.1,5 The data were presented at the 10th International Congress of Parkinson?s Disease and Movement Disorders (MDS) in Kyoto, Japan.

Health :: Highest Honor awarded to infectious disease experts from Harvard School of Public Health

Harvard School of Public Health (HSPH) has awarded its highest honor, for the promotion of high public health standards among vulnerable populations, to William H. Foege, former Director of the U.S. Centers for Disease Control and a founder of the Task Force for Child Survival and Development, and Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID). The two recipients have dedicated their lives to protecting people in this country and throughout the world from infectious diseases.

Breast Cancer :: Chemo drugs for treating breast cancer may cause changes in cognitive function

A new study investigating the effects of chemotherapy on cognitive function in mice has confirmed what many cancer patients receiving treatment have often complained about ? a decline in their memory and other cognitive functions, sometimes characterized as “chemobrain”.

Stroke :: AstraZeneca – SAINT II Trial Results Showed No Efficacy in Acute Ischaemic Stroke

Results from the SAINT II (Stroke Acute Ischemic NXY-059 Treatment) trial, announced today by AstraZeneca, showed that the investigational drug NXY-059 did not meet its primary outcome of a statistically significant reduction in stroke-related disability, as assessed by the modified Rankin Scale (mRS) (p=0.33, odds ratio 0.94) compared to placebo.

Colorectal Cancer :: Mesalazine to prevent colorectal cancer in IBD

Speaking at a Ferring-sponsored symposium on the occasion of the 14th United European Gastroenterology Week (UEGW) congress, Christoph Gasche, Associate Professor of Medicine, Medical University of Vienna, Austria presented the findings of an in-vitro study which for the first time demonstrates a mode of action by which mesalazine may reduce the risk of colorectal cancer in Inflammatory Bowel Disease (IBD) patients.

Heart Disease :: Special bra for women who have had heart surgery

Dr. Kathryn King, a University of Calgary researcher developed the new compression bra as a result of complaints from women who experience numbness, tingling and shooting sensations in their breasts after heart surgery. King’s design stops the weight of the breast from putting pressure on the surgical wound and also allows women to wear a bra immediately after the operation, instead of three or four days later.

Heart Disease :: Ottawa to invest $8.4-million to combat heart disease

Ottawa will invest $8.4-million over the next two years to develop a new heart health strategy, the Health Minister says. The money will initially be used to determine the extent of cardiovascular disease in Canada, and hypertension in particular, and then to shape a plan of attack, Tony Clement said.

Flu :: GlaxoSmithKline?s new generation flu vaccine shows a significant seroprotection

New data released today demonstrate significantly better immune responses in the age range 65 and above when vaccinated with GSK?s new generation (adjuvanted) seasonal flu vaccine compared to a traditional seasonal flu vaccine. These new data are highly important, since the disease burden and death toll is highest among the elderly in each flu season. The data, presented at the Influenza Vaccines for the World (IVW) 2006 Congress, showed the seroprotection rate (90.5%) achieved by the new adjuvanted vaccine in the elderly to be more than 25% higher than that reported in the age matched comparator group.